Company Ocata Therapeutics Inc
Equities
US67457L1008
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
President | - | - | |
John Heffernan
PRN | Corporate Officer/Principal | - | 15-02-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 51 | - | |
Masaaki Hirano
BRD | Director/Board Member | 57 | - |
Toru Yoshimitsu
BRD | Director/Board Member | 61 | - |
President | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,300,462 | 38,904,811 ( 91.97 %) | 0 | 91.97 % |
Company contact information
Astellas Institute for Regenerative Medicine
33 Locke Drive
01752, Marlborough
+508-756-1212
https://www.ocata.comSector
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+5.04% | 22.67B | |
-9.68% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- Stock
- Company Ocata Therapeutics Inc